Pharmaceutical Business review

Hitachi receives FDA clearance for proton therapy system

Proton Beam therapy is a new and remarkable type of cancer treatment that minimizes the unnecessary irradiation to the normal tissue compared with conventional electron beam and x-ray radiation therapy.

With this newly-developed technology, Hitachi expects to enhance its presence and position in the proton beam market in North America.